Abnormal cellular bioenergetics is central to the pathophysiology of obesity, diabetes, cancer, neurodegenerative and cardiovascular disease.Yet the ability to measure bioenergetics in vitro, quickly and reliably continues to be a key challenge for researchers.Seahorse Bioscience will introduce how Extracellular Flux (XF) allows you to quantify physiological changes in cellular bioenergetics by measuring the two major energy yielding pathways, mitochondrial respiration and glycolysis, in a sensitive and convenient microplate format.